TIMI Risk Score (NSTEMI)
Guide therapeutic decisions in non-ST elevation MI.
Although not absolute, the TIMI risk score has been shown to be useful to guide therapeutic decisions.
Patients with a TIMI score ≥ 3 benefited from an early invasive strategy.
Patients with a TIMI score ≥ 4 benefited from enoxaparin (as opposed to unfractionated heparin) and the addition of a IIb:IIIa inhibitor (Tirofiban) to heparin.
Antman et al.
Cannon CP et al.
Morrow DA et al.
Marc S Sabatine et al.